AAAAAA

   
Results: 1-3 |
Results: 3
Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen andcartilage aggrecan in rheumatoid arthritis but not in osteoarthritis
Authors: Manicourt, DH Poilvache, P van Egeren, A Devogelaer, JP Lenz, ME Thonar, EJMA
Citation: Dh. Manicourt et al., Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen andcartilage aggrecan in rheumatoid arthritis but not in osteoarthritis, ARTH RHEUM, 43(2), 2000, pp. 281-288
Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably inrheumatoid arthritis patients who have begun activity after a night of bedrest
Authors: Manicourt, DH Poilvache, P Nzeusseu, A van Egeren, A Devogelaer, JP Lenz, ME Thonar, EJMA
Citation: Dh. Manicourt et al., Serum levels of hyaluronan, antigenic keratan sulfate, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 change predictably inrheumatoid arthritis patients who have begun activity after a night of bedrest, ARTH RHEUM, 42(9), 1999, pp. 1861-1869
Treatment with calcitonin suppresses the responses of bone, cartilage, andsynovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions
Authors: Manicourt, DH Altman, RD Williams, JM Devogelaer, JP Druetz-Van Egeren, A Lenz, ME Pietryla, D Thonar, EJMA
Citation: Dh. Manicourt et al., Treatment with calcitonin suppresses the responses of bone, cartilage, andsynovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions, ARTH RHEUM, 42(6), 1999, pp. 1159-1167
Risultati: 1-3 |